| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $9,452,165,468 | 44,554,162 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $2,098,884,503 | 11,668,897 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,090,035,758 | 36,178,566 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $893,298,514 | 42,864,612 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $337,130,743 | 3,810,248 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $225,648,303 | 1,545,113 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $153,651,351 | 6,702,349 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $138,725,357 | 11,877,171 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $130,825,939 | 2,520,731 | SOLE | |||
| Invitae Corporation | Note 1.5% 4/1/2028 | 46185LAD5 | $130,372,500 | 300,000,000 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $119,792,559 | 2,368,378 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $95,511,286 | 20,763,323 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $89,992,591 | 12,710,818 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $78,334,371 | 4,578,280 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $76,879,940 | 4,865,819 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $74,500,526 | 2,691,493 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $74,341,830 | 151,215 | SOLE | |||
| SpringWorks Therapeutics, Inc. | COM | 85205L107 | $69,356,440 | 2,999,846 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $66,030,560 | 4,750,400 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $65,320,649 | 5,640,816 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $61,410,191 | 1,409,784 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $48,802,352 | 2,809,577 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $48,717,401 | 1,366,547 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $47,284,022 | 2,292,003 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $31,282,616 | 10,123,824 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $31,158,882 | 17,310,490 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $30,513,503 | 3,882,125 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $29,019,138 | 2,108,949 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $28,656,079 | 1,062,123 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $27,927,992 | 17,239,501 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $26,644,410 | 1,963,479 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $26,367,329 | 3,157,764 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $25,675,988 | 751,639 | SOLE | |||
| Cabaletta Bio, Inc. | COM | 12674W109 | $24,260,680 | 1,594,000 | SOLE | |||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $23,548,095 | 4,916,095 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $19,875,399 | 14,614,264 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $19,712,344 | 169,934 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $18,783,188 | 1,416,530 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $16,952,223 | 843,814 | SOLE | |||
| Immunovant, Inc. | COM | 45258J102 | $16,316,096 | 425,009 | SOLE | |||
| Cogent Biosciences, Inc. | COM | 19240Q201 | $12,606,419 | 1,292,966 | SOLE | |||
| Day One Biopharmaceuticals, Inc. | COM | 23954D109 | $12,270,000 | 1,000,000 | SOLE | |||
| Prime Medicine, Inc. | COM | 74168J101 | $9,811,566 | 1,028,466 | SOLE | |||
| 2seventy bio, Inc. | COM | 901384107 | $9,790,302 | 2,497,526 | SOLE | |||
| Relay Therapeutics, Inc. | COM | 75943R102 | $9,756,584 | 1,160,117 | SOLE | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | $9,416,980 | 1,127,782 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $8,660,750 | 343,000 | SOLE | |||
| Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | $8,556,040 | 10,969,282 | SOLE | |||
| Tango Therapeutics, Inc. | COM | 87583X109 | $8,445,000 | 750,000 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $8,375,628 | 8,131,678 | SOLE |